Mark Humayun, MD, PhD, receives National Medal of Technology and Innovation for Argus II research

Mark S. Humayun, MD, PhD, received the National Medal of Technology and Innovation from President Barack Obama on May 19, according to the American Academy of Ophthalmology.

Humayun, of USC Roski Eye Institute, was recognized for his role in developing the Argus II retinal prosthesis (Second Sight), which restores functional vision in patients with retinitis pigmentosa.

Mark Humayun and President Barack Obama

“Dr. Mark Humayun is a gifted clinician and a profoundly impactful investigator. His sustained pursuit of one of the holy grails of ophthalmology — to generate a sense of vision where none naturally exists — has changed forever our options in managing some forms of retinal blindness,” David W. Parke II, MD, CEO of the AAO, said in a statement. “The profession is proud of his accomplishments and delighted that they have been nationally recognized and celebrated.”

The Argus II implant is approved by the FDA and has CE mark designation in Europe. It is currently being investigated in the treatment of age-related macular degeneration.

Humayun and colleagues published a study in Ophthalmology in August 2015 showing that 29 of 30 patients had functioning Argus II systems 3 years after implantation. Overall, the device improved visual function.

The National Medal of Technology and Innovation was created in 1980 and recognizes individuals who make enduring contributions to U.S. competitiveness and quality of life and contribute to the country’s technological workforce.

Reference:

Ho AC, et al. Ophthalmology. 2015;doi:10.1016/j.ophtha.2015.04.032.